Excessive calcium influx is a major driver of retinal cell death and a hallmark of pathological processes triggered by retinal injury and disease. 1 Finding new ways to stop aberrant calcium entry is imperative in order to develop better therapeutics for preventing visual impairment and blindness. This effort requires an important balance between targeting the pathological functions of the players involved in calcium-mediated excitotoxicity while ensuring that their physiological functions remain intact. The L-type class of voltage-gated calcium channels is one of the culprits implicated in calcium-mediated excitotoxicity. An increase in synaptic excitation and neuronal depolarization can lead to enhanced activation of L-type channels, prolonged inward calcium currents and an accumulation of intracellular calcium ions. In retinal ganglion cells (RGCs) -the output neurons of the retina -L-type channels have been shown to be the only calcium channel subtype to mediate calcium currents in both the soma as well as in RGC axons. 2 From this recent finding, it is tempting to speculate that blocking L-type channels in RGCs could be an effective therapeutic approach for preventing calcium-mediated degeneration in both the retina and optic nerve.
However, generally blocking the L-type calcium channels themselves will likely interfere with numerous L-type-dependent physiological processes, ranging from pacemaker activity to gene expression to secretion. An alternative therapeutic strategy for treating excitotoxic disorders is to identify individual modulators of L-type calcium channels which would be predicted to target pathological processes with increased specificity. The neuropeptide somatostatin is a key regulator of neuronal excitability in the retina. All five subtypes of G-protein coupled receptors for somatostatin (sst 1 -5 ) are expressed in the retina, and there are well-established roles for sst 1 -and sst 2 -mediated signaling in visual processing and retinal homeostasis. 1 In contrast, the sst 4 receptor has been the neglected child of the somatostatin receptor family, with little known concerning its physiological relevance. 3 In a recent impactful study, the labora- remains to be confirmed in acutely dissociated adult RGCs, the similarities found between the neonatal and adult cells strongly suggest developmental continuity. The unexpected twist in this study is the unusual suspects identified as mediating the inhibition of calcium channels via sst 4 . 5 The authors show that in RGCs, calcium channel inhibition does not occur through the canonical Ga i/o -mediated signaling pathway typically downstream of sst 4 activation. 3 Rather, they propose that sst 4 couples to the pertussis toxin-insensitive Ga q in RGCs. In support, they find that blocking PKC -which is downstream of Ga q activation -reduces the inhibition of calcium channels by L-808,087. Along with the contribution of PKC to the sst 4 -mediated inhibition of calcium currents in RGCs, the authors show that Gbg is also required for a portion of the calcium current inhibition by L-803,087. Inhibition of voltage-gated calcium channels by Gbg is typically voltage-dependent and reversed by strong depolarizing prepulses, 6 yet Farrell and colleagues find that all sst 4 -mediated inhibition of calcium currents is voltage-independent. Finally, the effects of Gbgand PKC-mediated signaling on calcium channels are additive: blocking both signaling pathways together completely abolishes the sst 4 -mediated inhibition of calcium currents. Thus, in RGCs, the sst 4 receptor appears to activate distinct Ga q / PKC-and Gbg-dependent signaling pathways, which converge to mediate the inhibition of putative L-type calcium channels. Tapping into this unique endogenous sst 4 system may be an effective therapeutic strategy to selectively prevent calcium-mediated 
